Skip to main content
  • AHA: Botulinum Toxin Misses Mark in Stopping Afib

    Injection around the heart falls short in prevent post-op arrhythmia

    ANAHEIM – An attempt to reduce atrial fibrillation following cardiac surgery by injecting botulinum toxin into epicardial fat pads missed its clinical trial goal, but researchers said here that the proposal may yet prove useful.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details